🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The trial is designed as a randomised, controlled, open, parallel group, mu...
Status
Completed
Location
Birmingham Heartlands Hospital
Start Date
2018-07-16
Trial ID
NCT06212596
Treatments Being Tested
This is a phase 1b study of investigational drug selinexor in combination w...
Status
Completed
Location
Princess Margaret Cancer Centre
Start Date
2017-05-16
Trial ID
NCT03042819
Treatments Being Tested
Primary central nervous system diffuse large B-cell lymphoma (PCNSL-DLBCL) ...
Status
Recruiting
Location
Beijing Tongren Hospital, Capital Medical University
Start Date
2026-04-01
Trial ID
NCT07523737
Treatments Being Tested
A multicenter, single-arm clinical study of evaluate the efficacy and safet...
Status
Not Yet Recruiting
Location
Ruijin Hospital of Shanghai Jiaotong University
Start Date
2025-01-01
Trial ID
NCT06765928
Treatments Being Tested
The main purpose of this study is to see whether the combination of selinex...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2014-12
Trial ID
NCT02283359
Treatments Being Tested
Multiple myeloma (MM) is an incurable plasma cell cancer that almost all pa...
Status
Unknown
Location
Shanghai Changzheng Hospital
Start Date
2022-01-27
Trial ID
NCT04941937
Treatments Being Tested
This is a prospective, single-arm, multi-center clinical trial to evaluate ...
Status
Recruiting
Location
Changzhou Municipal No.1 People's Hospital
Start Date
2023-02-20
Trial ID
NCT05736965
Treatments Being Tested
Selinexor, a first-in-class, oral selective exportin 1 (XPO1) inhibitor, ha...
Status
Recruiting
Location
Berenson Cancer Center
Start Date
2024-08-06
Trial ID
NCT06225310
Treatments Being Tested
This is a prospective, single-arm, multi-center, phase II clinical trial to...
Status
Recruiting
Location
Sun yat-sen university cancer center
Start Date
2024-08-01
Trial ID
NCT06517511
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of Seline...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2022-08-01
Trial ID
NCT05974085
Treatments Being Tested